New insider activity at CVS Health ( (CVS) ) has taken place on May 7, 2025.
Director Larry Robbins has made a significant move by selling 3,750,000 shares of CVS Health stock, amounting to a substantial transaction worth $253,674,158.
Spark’s Take on CVS Stock
According to Spark, TipRanks’ AI Analyst, CVS is a Outperform.
CVS Health presents a compelling investment case with strong financial growth and operational stability. Positive earnings guidance and strategic leadership changes further enhance its prospects, though leverage and specific segment challenges pose risks. The stock’s reasonable valuation and solid dividend yield add to its appeal.
To see Spark’s full report on CVS stock, click here.
More about CVS Health
YTD Price Performance: 52.95%
Average Trading Volume: 10,762,315
Technical Sentiment Signal: Buy
Current Market Cap: $85.34B